MAL2 and ovarian cancer: The frequent overexpression of MAL2 in CRC primary tumor tissues and its low expression in non-cancerouslesions, implieda potential application for MAL2 in tumor monitoring and detection, particularly in high-grade carcinoma, which was consistent with the previous study of MAL2 in breast and ovarian cancer[11,18–20].